|
Name |
2,3-didehydro-19alpha-hydroxy-14-epicochlioquinone B
|
Molecular Formula | C28H38O7 | |
IUPAC Name* |
(1S,3R,4aR,6aS,12aR,12bS)-1-hydroxy-3-(2-hydroxypropan-2-yl)-6a,12b-dimethyl-9-[(E,2S)-4-methyl-3-oxohex-4-en-2-yl]-1,2,3,4a,5,6,12,12a-octahydropyrano[3,2-a]xanthene-8,11-dione
|
|
SMILES |
C/C=C(\C)/C(=O)[C@@H](C)C1=CC(=O)C2=C(C1=O)O[C@]3(CC[C@@H]4[C@@]([C@H]3C2)([C@H](C[C@@H](O4)C(C)(C)O)O)C)C
|
|
InChI |
InChI=1S/C28H38O7/c1-8-14(2)23(31)15(3)16-11-18(29)17-12-19-27(6,35-25(17)24(16)32)10-9-21-28(19,7)20(30)13-22(34-21)26(4,5)33/h8,11,15,19-22,30,33H,9-10,12-13H2,1-7H3/b14-8+/t15-,19-,20-,21+,22+,27-,28-/m0/s1
|
|
InChIKey |
GWQYUHGJJNBHJP-RLGURTFRSA-N
|
|
Synonyms |
2,3-didehydro-19alpha-hydroxy-14-epicochlioquinone B
|
|
CAS | NA | |
PubChem CID | 71471741 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 486.6 | ALogp: | 2.7 |
HBD: | 2 | HBA: | 7 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 110.0 | Aromatic Rings: | 4 |
Heavy Atoms: | 35 | QED Weighted: | 0.454 |
Caco-2 Permeability: | -4.841 | MDCK Permeability: | 0.00001250 |
Pgp-inhibitor: | 0.021 | Pgp-substrate: | 0.24 |
Human Intestinal Absorption (HIA): | 0.008 | 20% Bioavailability (F20%): | 0.004 |
30% Bioavailability (F30%): | 0.004 |
Blood-Brain-Barrier Penetration (BBB): | 0.361 | Plasma Protein Binding (PPB): | 91.21% |
Volume Distribution (VD): | 1.579 | Fu: | 9.71% |
CYP1A2-inhibitor: | 0.424 | CYP1A2-substrate: | 0.716 |
CYP2C19-inhibitor: | 0.033 | CYP2C19-substrate: | 0.547 |
CYP2C9-inhibitor: | 0.14 | CYP2C9-substrate: | 0.205 |
CYP2D6-inhibitor: | 0.568 | CYP2D6-substrate: | 0.124 |
CYP3A4-inhibitor: | 0.457 | CYP3A4-substrate: | 0.487 |
Clearance (CL): | 9.196 | Half-life (T1/2): | 0.676 |
hERG Blockers: | 0.274 | Human Hepatotoxicity (H-HT): | 0.497 |
Drug-inuced Liver Injury (DILI): | 0.031 | AMES Toxicity: | 0.029 |
Rat Oral Acute Toxicity: | 0.235 | Maximum Recommended Daily Dose: | 0.956 |
Skin Sensitization: | 0.69 | Carcinogencity: | 0.071 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.028 |
Respiratory Toxicity: | 0.961 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003007 | 0.788 | D0W2EK | 0.290 | ||||
ENC003011 | 0.786 | D0P0HT | 0.250 | ||||
ENC003638 | 0.614 | D0E9KA | 0.250 | ||||
ENC004572 | 0.613 | D0F7NQ | 0.242 | ||||
ENC002182 | 0.613 | D08BDT | 0.240 | ||||
ENC001862 | 0.540 | D09WYX | 0.240 | ||||
ENC002674 | 0.537 | D04SFH | 0.238 | ||||
ENC005795 | 0.500 | D0Q4SD | 0.238 | ||||
ENC000943 | 0.492 | D06IIB | 0.238 | ||||
ENC005797 | 0.460 | D0EP0C | 0.234 |